Skip to main content

Recognition and treatment of genitourinary complications in paediatric Crohn’s disease using Infliximab

Buy Article:

$48.00 plus tax (Refund Policy)



Although genitourinary complications of Crohn’s are well recognized, available information regarding their clinical course and management is sparse especially in the paediatric population. We report a myriad of urological complications in five paediatric cases, our experience from a tertiary paediatric urological and gastroenterological centre. All children with urological complications had severe Crohn’s disease which necessitated the use of immuno-suppressants including Infliximab. Three of four children healed and closed their fistulas after treatment, although failed to avoid future surgery, albeit for other reasons. Conclusion: 

We suggest Infliximab should be considered as a treatment option but in the absence of a common consensus, treatment be tailored to individual cases.

Keywords: Crohn’s disease; Fistula; Inflammatory bowel disease; Infliximab; Nephrolithiasis; Paediatrics; Renal; Stone; Surgery; Urinary tract

Document Type: Research Article


Affiliations: 1: Department of Paediatrics, Southampton University Hospital NHS Trust, Southampton, UK 2: Paediatric Urology Department, Great Ormond Street Hospital, London, UK 3: Department of Paediatric Gastroenterology, Great Ormond Street Hospital, London, UK

Publication date: July 1, 2010


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more